Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julien Hanson

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Trends in Pharmacological Sciences|October 26, 2005
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesisJean-Michel Dogné, Julien Hanson, Domenico Pratico
Future Medicinal Chemistry|May 10, 2022
Super-conserved receptors expressed in the brain: biology and medicinal chemistry effortsAlp Bayrak, Julien Hanson, Stefan Laufer, et al.
Trends in Pharmacological Sciences|September 28, 2011
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentialsMartina Lukasova, Julien Hanson, Sorin Tunaru, et al.
Pharmacology & Therapeutics|January 26, 2016
Insight into SUCNR1 (GPR91) structure and functionJulie Gilissen, François Jouret, Bernard Pirotte, et al.
Nature Reviews. Endocrinology|October 27, 2018
The causes and consequences of pituitary gigantismAlbert Beckers, Patrick Petrossians, Julien Hanson, et al.
Current Pharmaceutical Design|March 15, 2006
Coxibs and cardiovascular side-effects: from light to shadowJean-Michel Dogné, Julien Hanson, Claudiu Supuran, et al.
Biochemical Pharmacology|May 7, 2013
Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄Julien Hanson, Nerea Ferreirós, Bernard Pirotte, et al.
Biochemical Pharmacology|December 27, 2023
Basal interaction of the orphan receptor GPR101 with arrestins leads to constitutive internalizationDayana Abboud, Clauda Abboud, Asuka Inoue, et al.
Fundamental & Clinical Pharmacology|June 29, 2022
Receptor density influences the recruitment bias of aripiprazole and brexpiprazole at the dopamine D<sub>2L</sub> receptorMattia Ferraiolo, Romane Ponthot, Hicham Atik, et al.
Neuropharmacology|January 13, 2022
Dopamine D<sub>2</sub>L receptor density influences the recruitment of β-arrestin2 and G<sub>i</sub>1 induced by antiparkinsonian drugsMattia Ferraiolo, Hicham Atik, Romane Ponthot, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Trends in Pharmacological Sciences|October 26, 2005
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesisJean-Michel Dogné, Julien Hanson, Domenico Pratico
Future Medicinal Chemistry|May 10, 2022
Super-conserved receptors expressed in the brain: biology and medicinal chemistry effortsAlp Bayrak, Julien Hanson, Stefan Laufer, et al.
Trends in Pharmacological Sciences|September 28, 2011
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentialsMartina Lukasova, Julien Hanson, Sorin Tunaru, et al.
Pharmacology & Therapeutics|January 26, 2016
Insight into SUCNR1 (GPR91) structure and functionJulie Gilissen, François Jouret, Bernard Pirotte, et al.
Nature Reviews. Endocrinology|October 27, 2018
The causes and consequences of pituitary gigantismAlbert Beckers, Patrick Petrossians, Julien Hanson, et al.
Current Pharmaceutical Design|March 15, 2006
Coxibs and cardiovascular side-effects: from light to shadowJean-Michel Dogné, Julien Hanson, Claudiu Supuran, et al.
Biochemical Pharmacology|May 7, 2013
Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄Julien Hanson, Nerea Ferreirós, Bernard Pirotte, et al.
Biochemical Pharmacology|December 27, 2023
Basal interaction of the orphan receptor GPR101 with arrestins leads to constitutive internalizationDayana Abboud, Clauda Abboud, Asuka Inoue, et al.
Fundamental & Clinical Pharmacology|June 29, 2022
Receptor density influences the recruitment bias of aripiprazole and brexpiprazole at the dopamine D<sub>2L</sub> receptorMattia Ferraiolo, Romane Ponthot, Hicham Atik, et al.
Neuropharmacology|January 13, 2022
Dopamine D<sub>2</sub>L receptor density influences the recruitment of β-arrestin2 and G<sub>i</sub>1 induced by antiparkinsonian drugsMattia Ferraiolo, Hicham Atik, Romane Ponthot, et al.
Pageof 7